Canada drugs are less expensive because of the strict price-controls enforced by the Canadian Government with the help of the Patented Medicine Prices Review Board (PMPRB) branch of HealthCanada help regulate prices that pharmaceutical manufactures can charge. Similarly, drugs from other international countries have the same type of price controls enforced by the country’s government.
The mission of the PMPRB is to ensure that patented Canada drugs sold are not excessive in price. It specifically monitors the “factory-gate” price — the price that the drugs are sold by the manufacturer to hospitals, pharmacies and other drug wholesalers in Canada. The PMPRB does not regulate, nor does it have jurisdiction over, pharmacy dispensing fees. Governments of other countries outside of Canada and USA holds the similar missions to maintain price control on international drugs.